Literature DB >> 7530398

Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides.

E Khudyakov Yu1, N S Khudyakova, D L Jue, S B Lambert, S Fang, H A Fields.   

Abstract

A set of 150 synthetic peptides spanning the proteins NS3-NS4-NS5 of the hepatitis C virus (HCV) was synthesized and tested with a panel of 20 sera obtained from HCV-infected patients. Of 62 peptides prepared from the NS3 region, none exhibited strong antigenic reactivity. Rather, five peptides from this region demonstrated specific reactivity with only 5-10% of anti-HVC-positive sera. Nonetheless, it is well known that the NS3 region contains strong antigenic epitopes. These epitopes appear to be modeled in a functionally active manner with recombinant proteins and cannot be mimicked properly with short synthetic peptides. This finding suggests that the major NS3 antigenic epitopes are conformationally dependent. Seven of 20 peptides prepared from the NS4 region were immunoreactive. Five peptides from this region demonstrated very strong HCV-specific antigenic reactivity. Four of the five peptides belong to the recognized immunoreactive 5-1-1 region located inside the C100-3 antigen. One peptide demonstrating immunoreactivity with approximately 90% of anti-HCV-positive sera was found outside the C100-3 region at the C-terminal part of the NS4 protein. Of 68 peptides synthesized from the NS5 protein, 30 were immunoreactive. Six of the 30 demonstrated immunoreactivity with 35-50% of anti-HCV-positive sera. Thus, the NS4 and NS5 regions of the HCV polyprotein contain a large number of specific, broadly reactive, linear antigenic epitopes. The highly antigenic reactivity of the NS5 region suggests that this protein may have significant diagnostic potential.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7530398     DOI: 10.1016/s0042-6822(95)80086-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  5 in total

1.  Characterization of a panel of monoclonal antibodies and mapping the epitopes of hepatitis C virus proteins.

Authors:  O V Masalova; A G Abdulmedzhidova; S N Atanadze; E I Lakina; YuA Semiletov; A N Burkov; T I Ulanova; V V Novikov; V K Pimenov; G Filds; YuE Khudyakov; A A Kushch
Journal:  Dokl Biochem Biophys       Date:  2002 Mar-Apr       Impact factor: 0.788

2.  Characterization of a monoclonal antibody and its single-chain antibody fragment recognizing the nucleoside Triphosphatase/Helicase domain of the hepatitis C virus nonstructural 3 protein.

Authors:  Z X Zhang; U Lazdina; M Chen; D L Peterson; M Sällberg
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

3.  Antigenic heterogeneity of the hepatitis C virus NS5A protein.

Authors:  Xiao-Guang Dou; Ganesh Talekar; Joy Chang; Xing Dai; Lixia Li; Maria-Teresa Bonafonte; Brian Holloway; Howard A Fields; Yury E Khudyakov
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

4.  Restricted isotypic antibody reactivity to hepatitis C virus synthetic peptides in immunocompromised patients.

Authors:  M Devesa; A de Saez; G León; F Sirit; C Cosson; H Bermúdez; F Liprandi; O Noya; F H Pujol
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

5.  Significance of monoclonal antibodies against the conserved epitopes within non-structural protein 3 helicase of hepatitis C virus.

Authors:  Yixin Bian; Shuoxian Zhao; Shaomei Zhu; Jinfeng Zeng; Tingting Li; Yongshui Fu; Yuanzhan Wang; Xin Zheng; Ling Zhang; Wenjing Wang; Baocheng Yang; Yuanping Zhou; Jean-Pierre Allain; Chengyao Li
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.